Christine Devalck

Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial

Alina Ferster, C. Vermylen, G. Cornu et al. · Blood · 1996 · 284 citations · Full text

CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.

Laurence Brugières, Marie‐Cécile Le Deley, Hélène Pacquement et al. · PubMed · 1998 · 251 citations

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

Gianni Bisogno, Gian Luca De Salvo, Christophe Bergeron et al. · The Lancet Oncology · 2019 · 231 citations · Full text

Oncology, Metronomic Therapy, Rms 2005 +9

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

Alina Ferster, Parvine Tahriri, Christiane Vermylen et al. · Blood · 2001 · 218 citations · Full text

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

Gianni Bisogno, Meriel Jenney, Christophe Bergeron et al. · The Lancet Oncology · 2018 · 182 citations

Oncology, Medicine, Dose-intensified Doxorubicin +10